News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Bladder Cancer
centerforurologiccare.com
Nov 15, 2024, 12:02

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Bladder Cancer

Yakup Ergün, Medical Oncologist at Bower Hospital, shared a post on X:

“Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.

NIAGARA trial

Event Free Survival and Overall Survival.

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer

Authors: Thomas Powles,  James W.F. Catto, Matthew D. Galsky, Hikmat Al-Ahmadie, Joshua J. Meeks, Hiroyuki Nishiyama, Toan Quang Vu, Lorenzo Antonuzzo, Pawel Wiechno, Vagif Atduev, Ariel G. Kann, Tae-Hwan Kim, Cristina Suárez, Chao-Hsiang Chang, Florian Roghmann, Mustafa Özgüroğlu, Bernhard J. Eigl, Niara Oliveira, Tomas Buchler, Moran Gadot, Yousef Zakharia, Jon Armstrong, Ashok Gupta, Stephan Hois, Michiel S. van der Heijden.”

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Bladder Cancer

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Bladder Cancer

 

Ariel G. Kann Ashok Gupta Bernhard J. Eigl bladder cancer cancer Chao-Hsiang Chang Cristina Suárez event-free survival Florian Roghmann Hikmat Al-Ahmadie Hiroyuki Nishiyama James W.F. Catto Jon Armstrong Joshua J. Meeks Lorenzo Antonuzzo Matthew D. Galsky Michiel S. Van der Heijden Moran Gadot Mustafa Özgüroğlu Neoadjuvant chemotherapy (NACT) Niara Oliveira OncoDaily Oncology overall survival Pawel Wiechno Perioperative Durvalumab Stephan Hois Tae-Hwan Kim Thomas Powles Toan Quang Vu Tomas Buchler Vagif Atduev Yakup Ergün Yousef Zakharia
Special Coverage
Blog
Dec 21, 2024, 12:18
NCI Symposium on Translational Technology for Global Health
Blog
Dec 21, 2024, 12:14
Paolo Tarantino: Ending of a terrific 3-year cycle of PhD at The University of Milan
Blog
Dec 21, 2024, 11:52
Gevorg Tamamyan's first message as New POEM President
Blog
Dec 21, 2024, 11:30
Kyaw Thein: Tissue-Agnostic Drug Development in Cancer
Dialogues
Dec 21, 2024, 11:29
Beyond the Cancer Diagnosis: Dialogue with Marianne Arab, Hosted by Adrian Pogacian
Blog
Dec 21, 2024, 11:27
Aleix Prat: Carlos Fernandez de Larrea has been appointed as a Professor at the University of Barcelona
Blog
Dec 21, 2024, 11:25
Canadian Cancer Society - Natalie Wild's caregiver story
Blog
Dec 21, 2024, 11:24
Christy Brown: How many things can you dread more than 'your child has aggressive brain cancer?'
Blog
Dec 21, 2024, 11:18
Jose Fernando Moura: Pivotal SABCS24 summary hosted by Cancer Network
Blog
Dec 21, 2024, 11:18
Jérôme Salomon: President Macron, WHO Director-General and global health leaders inaugurate WHO Academy
Blog
Dec 21, 2024, 11:17
ChatGPT-Like AI Tool Promises to Speed Treatment Advances and Free Doctors’ Time by Matching Patients with Clinical Trials
Blog
Dec 21, 2024, 11:14
Mediamedic - Wenbin Zhou on Pyrotinib-based regimen in HER2-positive breast cancer